The Acute Effects of Different Stretching Methods in Individuals With Subacromial Impingement Syndrome
Launched by DOKUZ EYLUL UNIVERSITY · Aug 8, 2017
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
There is no information in literature about the acute effects of isolytic stretching exercise in individuals having subacromial impingement syndrome with glenohumeral internal rotation deficit. The purpose of this study is to investigate and compare the acute effects of isolytic and static stretching training in individuals having subacromial impingement syndrome with glenohumeral internal rotation deficit.
In modified cross body position, static stretching group will perform active-assistive static stretching by the physiotherapist whereas isolytic stretching group will perform active-ass...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of subacromial impingement syndrome
- • Glenohumeral internal rotation range of motion of the affected shoulder should be less than other shoulder and bilateral shoulder internal rotation range of motion difference should be ≥15 º
- • Pain with resisted arm elevation or external rotation as well as a minimum of 3 of 5 positive subacromial impingement syndrome tests, painful arc, pain or weakness with resisted external rotation, Neer, Hawkins and Jobe tests .
- • Ability to complete the entire study procedure
- Exclusion Criteria:
- • An inability to elevate the involved arm greater than 140 degree in the scapular plane
- • A 50% limitation of passive shoulder range of motion in \>2 planes of motion
- • Pain \>7/10
- • A history of fracture to the shoulder girdle
- • Systemic musculoskeletal disease
- • History of shoulder surgery,
- • Glenohumeral instability (positive apprehension, relocation or positive sulcus test) or positive findings for a full thickness rotator cuff tear (positive lag sign, positive drop arm test or marked weakness with shoulder external rotation)
About Dokuz Eylul University
Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, Balçova, Turkey
Patients applied
Trial Officials
Sevgi Sevi YESILYAPRAK, PhD
Study Director
Dokuz Eylul University
Damla GULPINAR, MS
Study Director
Izmir Katip Celebi University
Mehmet ERDURAN, MD
Study Director
Dokuz Eylul University
Cem OZCAN, MD
Study Director
Izmır Katip Celebi University Atatürk Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials